Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Swiss pharma industry behind in technology and clinical trials, index shows
By Thomson Reuters Nov 4, 2026 | 6:25 AM ZURICH, Nov 4 (Reuters) – Switzerland's pharmaceutical and chemicals industries are slipping behind when it comes to technology and clinical trials, a yearly Global Industry…
Why pharma firms are going to Earth's orbit in search of new cancer drugs
Roughly 300 miles above our heads, three washing machine-sized capsules are orbiting the Earth. Inside one of them, tiny crystals of a potential cancer drug are being grown in the weightlessness of space. The others are testing heat protection…
Royalty Pharma: Q3 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Wednesday reported third-quarter earnings of $145 million. The New York-based company said it had profit of 26 cents per share. Earnings, adjusted for non-recurring costs, were…
India's Alembic Pharma profit jumps on strong US sales
By Thomson Reuters Nov 4, 2026 | 4:50 AM Nov 4 (Reuters) – India's Alembic Pharmaceuticals posted an 81% rise in second-quarter profit on Wednesday, helped by strong sales in the US market, sending its shares surging 20%.
India's Aurobindo Pharma's quarterly profit rises by a third on strong US demand
By Thomson Reuters Nov 4, 2026 | 10:27 AM Nov 4 (Reuters) – Indian drugmaker Aurobindo Pharma reported a nearly 33% rise in second-quarter profit on Wednesday, led by strong demand and volume gains in its US market. •…
Rhythm Pharma (RYTM) Q3 2026 Earnings Call Transcript
Head of Investor Relations - Dave Connolly Chairman, Chief Executive Officer, and President - David Meeker Executive Vice President, Head of North America - Jennifer Lee Chief Financial Officer - Hunter Smith Executive Vice President, Head of…
Aurobindo Pharma's Q2 FY27 net up 32% at ₹1124 cr
Updated - November 04, 2026 at 08:57 PM. Aurobindo Phama's consolidated net profit increased 32.5 per cent at ₹1,124 crore in the second quarter of the current financial year ended September 30, 2026, compared to ₹848 crore in the…
Ennature Bio Pharma lists on NSE and BSE, targets branded nutraceuticals growth
Updated - November 04, 2026 at 05:38 PM. Ennature Bio Pharma Limited made its stock market debut on the National Stock Exchange and BSE on Wednesday, November 4, 2026. The company, a demerged division of India Glycols Limited. The company reported…
Astellas Pharma (OTCMKTS:ALPMY) Issues Quarterly Earnings Results
Astellas Pharma (OTCMKTS:ALPMY - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by ($0.06), Zacks reports. Astellas…
A CFO's Superpower in a Midterm Election: Planning for Multiple Scenarios
Good morning. Chief financial officers typically steer clear of politics. But in the lead-up to a big U.S election, such as yesterday's vote, they're also in their element, scenario-planning for possible outcomes. For many companies, Election Day…
Urogen Pharma (NASDAQ:URGN) Shares Down 16.3% on Disappointing Earnings
Urogen Pharma (NASDAQ:URGN - Get Free Report)'s stock price dropped 16.3% on Wednesday following a dissappointing earnings announcement. The stock traded as low as $29.35 and last traded at $28.80. 252,768 shares changed hands during trading, a…
Ascendis Pharma A/S (ASND) Expected to Release Earnings on Wednesday
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) is anticipated to issue its Q3 2026 results before the market opens on Wednesday, November 11th. Analysts expect the company to post earnings of $0.8940 per share and revenue of $409.37 million…
Emcure Pharma shares hit 10% upper circuit as Q2 net profit rises
Updated - November 04, 2026 at 10:26 AM. | Bengaluru Emcure Pharmaceuticals shares rallied 10 per cent to hit the upper circuit on Wednesday after the company reported a 29.31 per cent increase in consolidated net profit to ₹325.06 crore in…
NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Up After Earnings Beat
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report)'s stock price gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $19.90, but…
Royalty Pharma PLC $RPRX Stock Sold by Torray Investment Partners LLC
Torray Investment Partners LLC cut its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 6.2% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 564,461 shares of the…
Receive a Daily briefing on Pharma Industry News
Get Started